# ONDANSETRON
> **ANDA209389** · Abbreviated New Drug Application (Generic) · Sponsor: IPCA LABS LTD · Approved 2023-10-30
## Drug
- **FDA Application Number:** ANDA209389
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ONDANSETRON
- **Generic name:** ONDANSETRON
- **Active ingredients:** ONDANSETRON
- **Dosage form:** TABLET, ORALLY DISINTEGRATING
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** IPCA LABS LTD
- **Manufacturer:** Ipca Laboratories Limited
- **First approval:** 2023-10-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209389)
---
*AI Analytics · CC0 1.0*